NASDAQ:CLOV - Clover Health Investments Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $9.00
  • Forecasted Upside: 12.92 %
  • Number of Analysts: 5
  • Breakdown:
  • 3 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.97
▲ +0.08 (1.01%)

This chart shows the closing price for CLOV by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Clover Health Investments Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLOV and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLOV

Analyst Price Target is $9.00
▲ +12.92% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Clover Health Investments in the last 3 months. The average price target is $9.00, with a high forecast of $10.00 and a low forecast of $7.00. The average price target represents a 12.92% upside from the last price of $7.97.

This chart shows the closing price for CLOV for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 5 investment analysts is to sell stock in Clover Health Investments. This rating has held steady since August 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
4/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 2 sell ratings
7/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings
9/18/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings
10/18/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/9/2021CowenInitiated CoverageUnderperform$7.00Medium
9/2/2021CitigroupInitiated CoverageNeutral$10.00High
7/12/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$9.00High
6/10/2021Bank of AmericaDowngradeNeutral ➝ Underperform$10.00High
5/24/2021Bank of AmericaReiterated RatingBuy ➝ Neutral$15.00 ➝ $9.00N/A
5/19/2021Credit Suisse GroupLower Price TargetNeutral$10.00 ➝ $9.00Medium
5/18/2021CitigroupLower Price TargetBuy$13.00 ➝ $10.00Low
5/17/2021Bank of AmericaDowngradeBuy ➝ Neutral$15.00 ➝ $9.00High
3/9/2021Credit Suisse GroupInitiated CoverageNeutral$10.00High
3/3/2021CitigroupLower Price Target$19.00 ➝ $13.00High
2/2/2021CitigroupInitiated CoverageBuy$19.00N/A
2/1/2021JPMorgan Chase & Co.Initiated CoverageNeutral$15.00Low
2/13/2019HC WainwrightInitiated CoverageBuy$40.00 ➝ $40.00N/A
(Data available from 10/19/2016 forward)

News Sentiment Rating

0.65 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2021
  • 0 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2021
  • 0 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 7 very positive mentions
  • 16 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/21/2021
  • 13 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/20/2021
  • 9 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/19/2021
  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/19/2021

Current Sentiment

  • 3 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Clover Health Investments logo
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.
Read More

Today's Range

Now: $7.97
Low: $7.71
High: $8.13

50 Day Range

MA: $8.21
Low: $7.14
High: $10.80

52 Week Range

Now: $7.97
Low: $6.31
High: $28.85

Volume

318,895 shs

Average Volume

33,539,660 shs

Market Capitalization

$3.27 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.26

Frequently Asked Questions

What sell-side analysts currently cover shares of Clover Health Investments?

The following sell-side analysts have issued research reports on Clover Health Investments in the last twelve months: Bank of America Co., Citigroup Inc., Cowen Inc, Credit Suisse Group AG, JPMorgan Chase & Co., and Zacks Investment Research.
View the latest analyst ratings for CLOV.

What is the current price target for Clover Health Investments?

5 Wall Street analysts have set twelve-month price targets for Clover Health Investments in the last year. Their average twelve-month price target is $9.00, suggesting a possible upside of 12.9%. Bank of America Co. has the highest price target set, predicting CLOV will reach $10.00 in the next twelve months. Cowen Inc has the lowest price target set, forecasting a price of $7.00 for Clover Health Investments in the next year.
View the latest price targets for CLOV.

What is the current consensus analyst rating for Clover Health Investments?

Clover Health Investments currently has 3 sell ratings and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe CLOV will underperform the market and that investors should sell shares of Clover Health Investments.
View the latest ratings for CLOV.

What other companies compete with Clover Health Investments?

Other companies that are similar to Clover Health Investments include Bright Health Group, Trupanion, Alignment Healthcare, Oscar Health and Advanzeon Solutions.

How do I contact Clover Health Investments' investor relations team?

Clover Health Investments' physical mailing address is 317 University Ave Suite 200, Palo Alto CA, 94301. The company's listed phone number is 201-432-2133 and its investor relations email address is [email protected] The official website for Clover Health Investments is www.cloverhealth.com.